Skip to content
A service by Laboratorio Aclimu
Atlas
Genómico
Fictitious patient data · Not a medical result
Genomic report

Martín Fernando Gómez

42 years old · Male

Protocol
DEMO-2026-000123
Sample
14/07/2026
Issued
05/08/2026

You are seeing only the results that can change clinical managementYou are also seeing the results that change no clinical management

Levels C and D are replicated, but there is no evidence that knowing them improves an outcome: that is why the report does not open with them.

Nutrigenetics

Variants associated with nutrient metabolism and with dietary traits. The level of evidence is stated on each card: not all the associations have the same support, and they are worth reading with that label attached.

All 15 of your dietary traits, with their support stated

Your summary: 15 traits read — 4 with established clinical use, 2 with solid support and 9 with weaker support. Each card states its level of evidence.

Lactose tolerance

G/A
Lactase persistence (heterozygous)

You carry one copy of the lactase persistence variant. Lactose is generally tolerated, although symptoms may occur with high loads. A G/G result would indicate non-persistence. This position explains lactase persistence in European ancestry; in African or Middle Eastern ancestry other variants are involved that this chip does not measure, so there a G/G is not enough to claim non-persistence.

AEstablished clinical useHigh evidence
MCM6 / LCT · rs4988235dbSNP · rs4988235

Genetic risk of celiac disease

DQ2.5 negativo · DQ8 negativo
Very low genetic risk

More than 99% of people with celiac disease carry DQ2.5 or DQ8, so not having them makes the diagnosis very unlikely. It does not rule it out: these haplotypes are inferred from tag variants on the chip rather than from HLA typing, and cases with DQ2.2 or with a half heterodimer do exist. If there are symptoms, the diagnosis is made with serology and biopsy, not with this result.

AEstablished clinical useHigh evidence
HLA-DQA1 / DQB1 · DQ2.5 / DQ8GeneReviews · celiac disease

Alcohol metabolism

G/G
Normal enzyme activity

Without the ALDH2 deficiency variant (facial flushing). This does not imply that alcohol consumption is harmless.

AEstablished clinical useHigh evidence
ALDH2 · rs671dbSNP · rs671

Iron overload (hemochromatosis)

G/G
No risk variant

You do not carry the C282Y variant, which is responsible for most cases of hereditary hemochromatosis.

AEstablished clinical useHigh evidence

How quickly you break down alcohol

C/T
You convert alcohol into acetaldehyde faster

One copy of the fast variant. The first step of the breakdown speeds up and acetaldehyde builds up sooner, so discomfort from alcohol tends to appear with a smaller amount. It goes hand in hand with the ALDH2 result: if that enzyme also works slowly, the effects add up.

BSolid supportHigh evidence
ADH1B · rs1229984dbSNP · rs1229984

Triglycerides and blood fats

A/G
Tendency to somewhat higher triglycerides

One copy of the variant. It is associated with higher fasting triglycerides and with a larger rise after high-fat meals. This is an average tendency: the actual value is measured with a lipid panel.

BSolid supportHigh evidence
APOA5 · rs662799dbSNP · rs662799

Caffeine metabolism

A/C
Slow metabolizer

Caffeine is cleared more slowly. It has been associated with greater sensitivity to its effect on sleep and, in some studies, with higher cardiovascular risk at high intakes. The evidence is consistent but the effect is small.

CNo demonstrated change in managementModerate evidence
CYP1A2 · rs762551dbSNP · rs762551

Folate metabolism

C/T
Enzyme activity ~65% (heterozygous)

Very common in the general population. On its own it does NOT justify supplementing with methylfolate or ordering additional testing. Maintaining an adequate folate intake is the standard recommendation, the same as for anyone else.

CNo demonstrated change in managementModerate evidence
MTHFR · rs1801133 (C677T)dbSNP · rs1801133

Plant-based omega-3 conversion

G/T
Intermediate conversion

Intermediate capacity to convert ALA (of plant origin) into EPA/DHA. In diets without fish, a direct source of EPA/DHA may be favored.

CNo demonstrated change in managementModerate evidence
FADS1 · rs174537dbSNP · rs174537

Circulating vitamin D

A/C
Predisposition to somewhat lower levels

Associated with a lower concentration of vitamin D binding protein. The clinically useful measure remains 25-OH-vitamin D measured in blood, not the genotype.

CNo demonstrated change in managementModerate evidence
GC · rs2282679dbSNP · rs2282679

Caffeine, sleep, and jitteriness

C/T
Caffeine may make you somewhat jittery

One copy of the variant associated with more jitteriness and worse sleep at the same dose. The effect is small and is noticeable mainly with coffee in the afternoon.

CNo demonstrated change in managementModerate evidence
ADORA2A · rs5751876dbSNP · rs5751876

Appetite and feeling of fullness

T/C
Slight tendency toward more appetite

One copy of the variant. On average it is associated with somewhat more hunger and slightly higher body weight. The measured effect is a few hundred grams: it is real at the population level and very small at the level of an individual.

CNo demonstrated change in managementModerate evidence
MC4R · rs17782313dbSNP · rs17782313

Bitter taste perception

C/G
Intermediate perception

A trait with no clinical implication. It may influence preference for cruciferous vegetables (broccoli, cauliflower).

DExploratoryHigh evidence
TAS2R38 · rs713598dbSNP · rs713598

Preference for sweet foods

G/A
Slight tendency to prefer sweet foods

One copy of the variant associated with higher consumption of sugar and candy. FGF21 is a hormone involved in macronutrient preference; the association is consistent but the effect is small.

DExploratoryLimited evidence
FGF21 · rs838133dbSNP · rs838133

Salt sensitivity

A/G
Possible greater salt sensitivity

One copy of the variant. The studies associating it with higher blood pressure on high-sodium diets do not always replicate, and the effect is small.

DExploratoryLimited evidence
AGT · rs699dbSNP · rs699
Read it with this warning attached

Read each card with its evidence level in view, because this section mixes two kinds of result. Level A and B traits have established clinical support — lactose tolerance, alcohol metabolism or iron overload are not curiosities, and what those cards say holds. This warning is for the level C and D ones: for those, no study has shown that adjusting your diet according to the genotype improves a health outcome; the effects are small and are buried under everyday diet, weight, physical activity, and personal history. Anyone selling you a «DNA-based diet» built on that class of traits is selling you something the evidence does not support.